AI assistant
Roivant Sciences Ltd. — Director's Dealing 2025
Dec 18, 2025
30587_dirs_2025-12-17_f2af3a40-2b27-4a02-84bb-e25c805e5cbb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2025-12-15
Reporting Person: Gline Matthew (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-15 | Common Shares | M | 234096 | $4.06 | Acquired | 17521177 | Direct |
| 2025-12-15 | Common Shares | S | 230357 | $21.68 | Disposed | 17290820 | Direct |
| 2025-12-15 | Common Shares | J | 3739 | $21.68 | Disposed | 17287081 | Direct |
| 2025-12-15 | Common Shares | M | 1363711 | $12.68 | Acquired | 18650792 | Direct |
| 2025-12-15 | Common Shares | S | 566116 | $21.68 | Disposed | 18084676 | Direct |
| 2025-12-15 | Common Shares | J | 797595 | $21.68 | Disposed | 17287081 | Direct |
| 2025-12-15 | Common Shares | M | 2272852 | $12.68 | Acquired | 19559933 | Direct |
| 2025-12-15 | Common Shares | S | 943527 | $21.68 | Disposed | 18616406 | Direct |
| 2025-12-15 | Common Shares | J | 1329325 | $21.68 | Disposed | 17287081 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-15 | Stock Option (Right to Buy) | $4.06 | M | 234096 | Disposed | 2026-04-19 | Common Stock (234096) | Direct |
| 2025-12-15 | Stock Option (Right to Buy) | $12.68 | M | 1363711 | Disposed | 2026-03-31 | Common Stock (1363711) | Direct |
| 2025-12-15 | Stock Option (Right to Buy) | $12.68 | M | 2272852 | Disposed | 2026-03-31 | Common Stock (2272852) | Direct |
Footnotes
F1: All options exercised by the reporting person would have expired in March or April 2026 if not exercised. The transactions reported on this Form 4 represent the disposition of the entirety of the reporting person's stock options expiring in 2026. As of the date of this filing, the reporting person has disgorged to the Issuer the full amount of the disgorgable profits realized from the sale reported herein, as required by Section 16(b) of the Securities Exchange Act of 1934.
F2: Represents the "net settlement" by the Issuer of stock options previously granted to the reporting person in order to satisfy the exercise price applicable to such stock options.
F3: Award of stock options to purchase Common Shares that is fully vested.